216 related articles for article (PubMed ID: 26428318)
1. Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.
Lang M; Vocke CD; Merino MJ; Schmidt LS; Linehan WM
Mod Pathol; 2015 Nov; 28(11):1458-69. PubMed ID: 26428318
[TBL] [Abstract][Full Text] [Related]
2. The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
Boris RS; Benhammou J; Merino M; Pinto PA; Linehan WM; Bratslavsky G
J Urol; 2011 Jun; 185(6):2050-5. PubMed ID: 21496834
[TBL] [Abstract][Full Text] [Related]
3. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
[TBL] [Abstract][Full Text] [Related]
4. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
[TBL] [Abstract][Full Text] [Related]
5. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.
Mayr JA; Meierhofer D; Zimmermann F; Feichtinger R; Kögler C; Ratschek M; Schmeller N; Sperl W; Kofler B
Clin Cancer Res; 2008 Apr; 14(8):2270-5. PubMed ID: 18413815
[TBL] [Abstract][Full Text] [Related]
6. [Birt-Hogg-Dubé syndrome : bilateral oncocytic kidney tumors in a patient].
Westermann DH; Rüdiger T; Lohe B; Frohneberg D
Urologe A; 2010 Dec; 49(12):1527-31. PubMed ID: 20949256
[TBL] [Abstract][Full Text] [Related]
7. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
8. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
Gasparre G; Hervouet E; de Laplanche E; Demont J; Pennisi LF; Colombel M; Mège-Lechevallier F; Scoazec JY; Bonora E; Smeets R; Smeitink J; Lazar V; Lespinasse J; Giraud S; Godinot C; Romeo G; Simonnet H
Hum Mol Genet; 2008 Apr; 17(7):986-95. PubMed ID: 18156159
[TBL] [Abstract][Full Text] [Related]
9. Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.
Jikuya R; Johnson TA; Maejima K; An J; Ju YS; Lee H; Ha K; Song W; Kim Y; Okawa Y; Sasagawa S; Kanazashi Y; Fujita M; Imoto S; Mitome T; Ohtake S; Noguchi G; Kawaura S; Iribe Y; Aomori K; Tatenuma T; Komeya M; Ito H; Ito Y; Muraoka K; Furuya M; Kato I; Fujii S; Hamanoue H; Tamura T; Baba M; Suda T; Kodama T; Makiyama K; Yao M; Shuch BM; Ricketts CJ; Schmidt LS; Linehan WM; Nakagawa H; Hasumi H
EBioMedicine; 2023 Jun; 92():104596. PubMed ID: 37182269
[TBL] [Abstract][Full Text] [Related]
10. Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.
Pradella LM; Lang M; Kurelac I; Mariani E; Guerra F; Zuntini R; Tallini G; MacKay A; Reis-Filho JS; Seri M; Turchetti D; Gasparre G
Eur J Hum Genet; 2013 Oct; 21(10):1169-72. PubMed ID: 23386036
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of mitochondrial DNA D-loop region mutation and its significance in human oncocytoma].
Song WJ; Yan LM; Zhao XL; Liu ZH; Sun BC
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):767-70. PubMed ID: 21163068
[TBL] [Abstract][Full Text] [Related]
13. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.
Toro JR; Glenn G; Duray P; Darling T; Weirich G; Zbar B; Linehan M; Turner ML
Arch Dermatol; 1999 Oct; 135(10):1195-202. PubMed ID: 10522666
[TBL] [Abstract][Full Text] [Related]
14. Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
Klomp JA; Petillo D; Niemi NM; Dykema KJ; Chen J; Yang XJ; Sääf A; Zickert P; Aly M; Bergerheim U; Nordenskjöld M; Gad S; Giraud S; Denoux Y; Yonneau L; Méjean A; Vasiliu V; Richard S; MacKeigan JP; Teh BT; Furge KA
BMC Med Genomics; 2010 Dec; 3():59. PubMed ID: 21162720
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
16. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.
Schmidt LS; Nickerson ML; Warren MB; Glenn GM; Toro JR; Merino MJ; Turner ML; Choyke PL; Sharma N; Peterson J; Morrison P; Maher ER; Walther MM; Zbar B; Linehan WM
Am J Hum Genet; 2005 Jun; 76(6):1023-33. PubMed ID: 15852235
[TBL] [Abstract][Full Text] [Related]
17. Review of renal oncocytoma with focus on clinical and pathobiological aspects.
Kuroda N; Toi M; Hiroi M; Shuin T; Enzan H
Histol Histopathol; 2003 Jul; 18(3):935-42. PubMed ID: 12792905
[TBL] [Abstract][Full Text] [Related]
18. The genetics of renal oncocytosis: a possible model for neoplastic progression.
Al-Saleem T; Cairns P; Dulaimi EA; Feder M; Testa JR; Uzzo RG
Cancer Genet Cytogenet; 2004 Jul; 152(1):23-8. PubMed ID: 15193438
[TBL] [Abstract][Full Text] [Related]
19. A novel heterozygous mutation in the Birt-Hogg-Dubé Syndrome.
Gómez Rivas J; Carrión DM; Alonso Y Gregorio S; Álvarez-Maestro M; Tabernero Gómez Á; Cisneros Ledo J
Arch Esp Urol; 2017 Sep; 70(7):675-678. PubMed ID: 28891800
[TBL] [Abstract][Full Text] [Related]
20. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.
Houweling AC; Gijezen LM; Jonker MA; van Doorn MB; Oldenburg RA; van Spaendonck-Zwarts KY; Leter EM; van Os TA; van Grieken NC; Jaspars EH; de Jong MM; Bongers EM; Johannesma PC; Postmus PE; van Moorselaar RJ; van Waesberghe JH; Starink TM; van Steensel MA; Gille JJ; Menko FH
Br J Cancer; 2011 Dec; 105(12):1912-9. PubMed ID: 22146830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
